Fig. 3
From: Establishment of an innovative staging system for extramedullary plasmacytoma
Survival curves in 48 Extramedullary Plasmacytoma Patients. Overall survival (a), local relapse free survival (d) and disease-free survival (g) for 48 EMP patients and overall survival (b), local relapse free survival (e) and disease-free survival (h) according to the patients with lymph node metastasis (n = 13) or without lymph node metastasis (n = 25). Overall survival (c), local relapse free survival (f) and disease-free survival (i) between EMP patients with a tumor equal to or more than 5 cm (n = 24) or less than 5 cm (n = 24)